During the Trading Day
| 14.50 | +0.98 / +7.25% |
Data as of 4:00pm ET | Day’s Change | |
| 14.50 | 0.00 / 0.00% |
| Volume: 18.0K |
| SECTOR Health Technology | INDUSTRY Pharmaceuticals: Other | MARKET CAP $1.4B |
Company Description
VIVUS, Inc. is a biopharmaceutical company. It is engaged in the development and commercialization of therapeutic drugs for markets, including obesity and related morbidities, such as sleep apnea and diabetes and men's sexual health. The company's products include Qsymia Obesity, Qsymia Sleep Apnea, Qsymia Diabetes and Avanafil. The company was founded by Virgil A. Place on April 16, 1991 and is headquartered in Mountain View, CA.
Employees

Shareholders
| Other institutional | 56.89% |
| Mutual fund holders | 22.50% |
| Individual stakeholders | 1.28% |
Top Executives
| Peter Y. Tam, MBA | President & Director |
| Leland F. Wilson | Chief Executive Officer & Director |
| Guy P. Marsh, MBA | Vice President-Operations & General Manager |
| Timothy E. Morris, CPA | CFO & Senior VP-Global Corporate Development |
| Santosh T. Varghese, MD | VP, Head-Medical Affairs & Pharmacovigilance |